The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Several late-stage pipeline products have the potential to address some of these unmet needs
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
Enabling wireless monitoring In ambulances and homes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
